Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 10/2015

Open Access 01-10-2015 | Genetics (AP Morris, Section Editor)

Genetics of Type 2 Diabetes in African Americans

Author: Maggie C. Y. Ng

Published in: Current Diabetes Reports | Issue 10/2015

Login to get access

Abstract

Type 2 diabetes (T2D) is a global health problem showing substantial ethnic disparity in disease prevalence. African Americans have one of the highest prevalence of T2D in the USA but little is known about their genetic risks. This review summarizes the findings of genetic regions and loci associated with T2D and related glycemic traits using linkage, admixture, and association approaches in populations of African ancestry. In particular, findings from genome-wide association and exome chip studies suggest the presence of both ancestry-specific and shared loci for T2D and glycemic traits. Among the European-identified loci that are transferable to individuals of African ancestry, allelic heterogeneity as well as differential linkage disequilibrium and risk allele frequencies pose challenges and opportunities for fine mapping and identification of causal variant(s) by trans-ancestry meta-analysis. More genetic research is needed in African ancestry populations including the next-generation sequencing to improve the understanding of genetic architecture of T2D.
Literature
1.
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva; 2014
2.
3.
Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA; 2014
4.
Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311:1778–86.PubMedCentralCrossRefPubMed
5.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311:806–14.CrossRefPubMed
6.
Umpierrez GE, Gonzalez A, Umpierrez D, Pimentel D. Diabetes mellitus in the Hispanic/Latino population: an increasing health care challenge in the United States. Am J Med Sci. 2007;334:274–82.CrossRefPubMed
7.
Lora CM, Daviglus ML, Kusek JW, et al. Chronic kidney disease in United States Hispanics: a growing public health problem. Ethn Dis. 2009;19:466–72.PubMedCentralPubMed
8.
Beard HA, AlGhatrif M, Samper-Ternent R, Gerst K, Markides KS. Trends in diabetes prevalence and diabetes-related complications in older Mexican Americans from 1993–1994 to 2004–2005. Diabetes Care. 2009;32:2212–7.PubMedCentralCrossRefPubMed
9.
Collins AJ, Foley RN, Herzog C, et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis. 2010;55(S1–420):A426–7.
10.
11.
Jolly S, Vittinghoff E, Chattopadhyay A, Bibbins-Domingo K. Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. Am J Med. 2010;123:811–8.CrossRefPubMed
12.
Howard VJ, Kleindorfer DO, Judd SE, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619–27.PubMedCentralCrossRefPubMed
13.
LaVeist TA, Thorpe Jr RJ, Galarraga JE, Bower KM, Gary-Webb TL. Environmental and socio-economic factors as contributors to racial disparities in diabetes prevalence. J Gen Intern Med. 2009;24:1144–8.PubMedCentralCrossRefPubMed
14.
Ariza MA, Vimalananda VG, Rosenzweig JL. The economic consequences of diabetes and cardiovascular disease in the United States. Rev Endocr Metab Disord. 2010;11:1–10.CrossRefPubMed
15.
16.
Rotimi C, Cooper R, Cao G, Sundarum C, McGee D. Familial aggregation of cardiovascular diseases in African-American pedigrees. Genet Epidemiol. 1994;11:397–407.CrossRefPubMed
17.
Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. 2000;49:2201–7.CrossRefPubMed
18.
Velasco Mondragon HE, Charlton RW, Peart T, Burguete-Garcia AI, Hernandez-Avila M, Hsueh WC. Diabetes risk assessment in Mexicans and Mexican Americans: effects of parental history of diabetes are modified by adiposity level. Diabetes Care. 2010;33:2260–5.PubMedCentralCrossRefPubMed
19.
Rotimi CN, Chen G, Adeyemo AA, et al. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America diabetes Mellitus (AADM) Study. Diabetes. 2004;53:838–41.CrossRefPubMed
20.
Chen G, Adeyemo A, Zhou J, et al. Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: potential role of C-peptide. Diabetes Res Clin Pract. 2007;78:e1–6.CrossRefPubMed
21.
Sale MM, Lu L, Spruill IJ, et al. Genome-wide linkage scan in Gullah-speaking African American families with type 2 diabetes: the Sea Islands Genetic African American Registry (project SuGAR). Diabetes. 2009;58:260–7.PubMedCentralCrossRefPubMed
22.
Malhotra A, Igo Jr RP, Thameem F, et al. Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group. Diabetes Metab Res Rev. 2009;25:740–7.PubMedCentralCrossRefPubMed
23.
Elbein SC, Das SK, Hallman DM, Hanis CL, Hasstedt SJ. Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American diabetes association GENNID (genetics of NIDDM) study cohort. Diabetes. 2009;58:268–74.PubMedCentralCrossRefPubMed
24.
Hasstedt SJ, Highland HM, Elbein SC, Hanis CL, Das SK. Five linkage regions each harbor multiple type 2 diabetes genes in the African American subset of the GENNID Study. J Hum Genet. 2013;58:378–83.PubMedCentralCrossRefPubMed
25.
Manning AK, Hivert MF, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44:659–69.PubMedCentralCrossRefPubMed
26.••
Ng MC, Shriner D, Chen BH, et al. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet. 2014;10:e1004517. Large-scale meta-analysis of GWAS for type 2 diabetes in African Americans.PubMedCentralCrossRefPubMed
27.
28.
Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–5.CrossRefPubMed
29.
Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770–5.CrossRefPubMed
30.
Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.PubMedCentralCrossRefPubMed
31.
Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–6.CrossRefPubMed
32.•
Marullo L, El-Sayed Moustafa JS, Prokopenko I. Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits. Curr Diabet Rep. 2014;14:551. A review on the meta-analysis of GWAS for glycemic traits and their associations with T2D in European ancestry populations.CrossRef
33.
Grarup N, Sandholt CH, Hansen T, Pedersen O. Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond. Diabetologia. 2014;57:1528–41.CrossRefPubMed
34.
Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–90.PubMedCentralCrossRefPubMed
35.
Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44:991–1005.PubMedCentralCrossRefPubMed
36.
Imamura M, Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives [review]. Endocr J. 2011;58:723–39.CrossRefPubMed
37.
Hara K, Shojima N, Hosoe J, Kadowaki T. Genetic architecture of type 2 diabetes. Biochem Biophys Res Commun. 2014;452:213–20.CrossRefPubMed
38.
Williams AL, Jacobs SB, Moreno-Macias H, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2014;506:97–101.CrossRefPubMed
39.•
Palmer ND, McDonough CW, Hicks PJ, et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012;7:e29202. The first GWAS for type 2 diabetes in African Americans.PubMedCentralCrossRefPubMed
40.•
Chen G, Bentley A, Adeyemo A, et al. Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans. Hum Mol Genet. 2012;21:4530–6. The first GWAS for glycemic traits in African Americans.PubMedCentralCrossRefPubMed
41.
Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008;40:1098–102.CrossRefPubMed
42.
Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40:1092–7.CrossRefPubMed
43.
Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet. 2010;42:864–8.CrossRefPubMed
44.
Charles BA, Shriner D, Rotimi CN. Accounting for linkage disequilibrium in association analysis of diverse populations. Genet Epidemiol. 2014;38:265–73.CrossRefPubMed
45.
Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56–65.CrossRefPubMed
46.
Cooke JN, Ng MC, Palmer ND, et al. Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care. 2012;35:287–92.PubMedCentralCrossRefPubMed
47.
Palmer ND, Hester JM, An SS, et al. Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes. 2011;60:662–8.PubMedCentralCrossRefPubMed
48.
Haiman CA, Fesinmeyer MD, Spencer KL, et al. Consistent directions of effect for established type 2 diabetes risk variants across populations: the population architecture using genomics and epidemiology (PAGE) consortium. Diabetes. 2012;61:1642–7.PubMedCentralCrossRefPubMed
49.
Waters KM, Stram DO, Hassanein MT, et al. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet. 2010;6:e1001078.PubMedCentralCrossRefPubMed
50.
Keaton JM, Cooke Bailey JN, Palmer ND, et al. A comparison of type 2 diabetes risk allele load between African Americans and European Americans. Hum Genet. 2014;133:1487–95.CrossRefPubMed
51.
Carlson CS, Matise TC, North KE, et al. Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study. PLoS Biol. 2013;11:e1001661.PubMedCentralCrossRefPubMed
52.•
Ng MC, Saxena R, Li J, et al. Transferability and fine mapping of type 2 diabetes loci in African Americans: the Candidate Gene Association Resource Plus Study. Diabetes. 2013;62:965–76. Transferability study of type 2 diabetes loci in African Americans.PubMedCentralCrossRefPubMed
53.
Teo YY, Ong RT, Sim X, Tai ES, Chia KS. Identifying candidate causal variants via trans-population fine-mapping. Genet Epidemiol. 2010;34:653–64.CrossRefPubMed
54.••
Mahajan A, Go MJ, Zhang W, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46:234–44. Large-scale trans-ancestry meta-analysis of GWAS for type 2 diabetes.CrossRefPubMed
55.
Fesinmeyer MD, Meigs JB, North KE, et al. Genetic variants associated with fasting glucose and insulin concentrations in an ethnically diverse population: results from the Population Architecture using Genomics and Epidemiology (PAGE) Study. BMC Med Genet. 2013;14:98.PubMedCentralCrossRefPubMed
56.
Ramos E, Chen G, Shriner D, et al. Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans. Diabetologia. 2011;54:783–8.PubMedCentralCrossRefPubMed
57.•
Liu CT, Ng MC, Rybin D, et al. Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource. Diabetologia. 2012;55:2970–84. Transferability study glycemic loci in African Americans.PubMedCentralCrossRefPubMed
58.
Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105–16.PubMedCentralCrossRefPubMed
59.••
Wessel J, Chu AY, Willems SM, et al. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun. 2015;6:5897. Large scale trans-ancestry exome chip study for type 2 diabetes and glycemic traits.PubMedCentralCrossRefPubMed
60.••
Mahajan A, Sim X, Ng HJ, et al. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet. 2015;11:e1004876. Large scale exome chip study for glycemic traits in Europeans.PubMedCentralCrossRefPubMed
61.
62.
63.
Cheng CY, Reich D, Haiman CA, et al. African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts. PLoS One. 2012;7:e32840.PubMedCentralCrossRefPubMed
64.
Jeff JM, Armstrong LL, Ritchie MD, et al. Admixture mapping and subsequent fine-mapping suggests a biologically relevant and novel association on chromosome 11 for type 2 diabetes in African Americans. PLoS One. 2014;9:e86931.PubMedCentralCrossRefPubMed
65.
Klimentidis YC, Abrams M, Wang J, Fernandez JR, Allison DB. Natural selection at genomic regions associated with obesity and type-2 diabetes: East Asians and sub-Saharan Africans exhibit high levels of differentiation at type-2 diabetes regions. Hum Genet. 2011;129:407–18.PubMedCentralCrossRefPubMed
66.
Chen R, Corona E, Sikora M, et al. Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genet. 2012;8:e1002621.PubMedCentralCrossRefPubMed
67.•
Ayub Q, Moutsianas L, Chen Y, et al. Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes. Am J Hum Genet. 2014;94:176–85. Comprehensive examination of positive selection for GWAS loci for type 2 diabetes.PubMedCentralCrossRefPubMed
68.
Corona E, Chen R, Sikora M, et al. Analysis of the genetic basis of disease in the context of worldwide human relationships and migration. PLoS Genet. 2013;9:e1003447.PubMedCentralCrossRefPubMed
69.
Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–62.PubMedCentralPubMed
Metadata
Title
Genetics of Type 2 Diabetes in African Americans
Author
Maggie C. Y. Ng
Publication date
01-10-2015
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 10/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0651-0

Other articles of this Issue 10/2015

Current Diabetes Reports 10/2015 Go to the issue

Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Novel Therapies in Development for Diabetic Macular Edema

Genetics (AP Morris, Section Editor)

Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Obesity-Related Traits

Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)

Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes

Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

Mechanisms of Beta Cell Dysfunction Associated With Viral Infection

Immunology and Transplantation (A Pileggi, Section Editor)

The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Vascular Smooth Muscle as a Target for Novel Therapeutics
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits